Revenue

9 Months Ended

Mar. 31, 2024

Revenue

Revenue [Text Block]

Note 7. Revenue

As of March 31, 2024 and June 30, 2023, the net rebate liability was $222,645 and $191,459, respectively. The rebate liability is included in accrued expenses within the accompanying condensed consolidated balance sheets. As of March 31, 2024 and June 30, 2023, the allowance for sales discounts was $9,666 and $13,589, respectively. The allowance for sales discounts is included in trade accounts receivable, less allowance for doubtful accounts in the accompanying condensed consolidated balance sheets.

The following table disaggregates revenue by major product category for the three and nine months ended March 31:

		Three Months Ended March 31,				Nine Months Ended March 31,
		2024		2023		2024		2023
Physical Therapy and Rehabilitation Products	$	3,656,363	$	4,735,741	$	12,631,415	$	17,399,296
Orthopedic Soft Bracing Products		3,980,170		4,476,849		12,464,521		14,698,238
Other		21,313		23,447		65,175		74,260
	$	7,657,846	$	9,236,037	$	25,161,111	$	32,171,794